Robert J Chilton

Professor, Medicine, Division of Cardiology

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Robert J Chilton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

3392 Citations
27 h-Index
61 Article
43 Review article
9 Editorial
7 Comment/debate
More

Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors
Nashawi, M., Sheikh, O., Battisha, A., Ghali, A. & Chilton, R., May 2021, In: Heart Failure Reviews. 26, 3, p. 643-652 10 p.
Research output: Contribution to journal › Review article › peer-review
1 Scopus citations
Sglt2 inhibitors: A narrative review of efficacy and safety
Nelinson, D. S., Sosa, J. M. & Chilton, R. J., Feb 2021, In: Journal of the American Osteopathic Association. 121, 2, p. 229-239 11 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
糖尿病和卒中:一个重要的并发症
Bloomgarden, Z. & Chilton, R., Mar 2021, In: Journal of Diabetes. 13, 3, p. 184-190 7 p.
Research output: Contribution to journal › Editorial › peer-review

Open Access
A focused review of cardiovascular guideline related recommendations for the primary care physician in the USA
Sheikh, O., Nashawi, M., Battisha, A. & Chilton, R., 2020, In: Cardiovascular Endocrinology and Metabolism. 9, 2, p. 36-41 6 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
A new perspective on lowering CV risk from hypoglycaemia
Solis-Herrera, C., Sheikh, O. & Chilton, R., Jan 1 2020, In: European Heart Journal. 41, 2, p. 218-220 3 p.
Research output: Contribution to journal › Review article › peer-review

Open Access

1 Scopus citations

SGLT2 inhibitors may have great potential in reducing HF in diabetes
Robert J Chilton
7/23/19 → 7/24/19
2 items of Media coverage
Press/Media: Press / Media
Cardiologists Must 'Get Up To Speed' on Treating Diabetes
Robert J Chilton
6/19/19 → 6/20/19
2 items of Media coverage
Press/Media: Press / Media
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy; SMART CRT
Robert J Chilton
10/2/18
1 item of Media coverage
Press/Media: Press / Media
OrexigenÂ Therapeutics Announces Multiple ContraveÂ Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society
Robert J Chilton
9/30/17
1 item of Media coverage
Press/Media: Press / Media